- Home
- GCV vs CBUS Comparison
GCV vs CBUS Comparison
Compare GCV & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GCV | CBUS |
|---|---|---|
| Founded | 1988 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Agricultural Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.1M | 69.9M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | GCV | CBUS |
|---|---|---|
| Price | $4.09 | $1.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 57.9K | ★ 172.1K |
| Earning Date | 01-01-0001 | 11-13-2025 |
| Dividend Yield | ★ 13.04% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,794,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $109.96 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.15 | $1.09 |
| 52 Week High | $4.58 | $3.50 |
Technical Indicators
Market Signals| Indicator | GCV | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 43.74 | 60.60 |
| Support Level | $3.98 | $1.49 |
| Resistance Level | $4.30 | $1.75 |
| Average True Range (ATR) | 0.07 | 0.14 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 41.12 | 84.78 |
Price Performance
Historical ComparisonAbout GCV Gabelli Convertible and Income Securities Fund Inc. (The)
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive and others. All the operation of the group is operated through the regions of United States.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.